NeuPath Health to Expand Digital Health Capabilities

NeuPathNews

TORONTO, ONTARIO, October 5, 2020 – NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, announced today an initiative to expand the Company’s digital health capabilities. Pivot Design Group (“Pivot”) – a leading Toronto boutique strategic design and communications agency specializing in service design, user experience design and communication design – will work with NeuPath, its physicians, healthcare providers, and patients to translate research and insights into proprietary digital health solutions designed to provide chronic pain patients with multi-modal care and the tools needed to live a complete and fulfilled life.

“As we’ve seen in our own business, the pandemic has accelerated the adoption and need for digital and virtual health solutions. Chronic pain costs governments, insurance carriers, employers, and patients $60 billion per year in Canada and $560 billion in the US; a chronic pain-focused virtual health solution will allow us to reach more patients in a far more scalable manner,” stated NeuPath CEO, Grant Connelly. “Outside of our business, transactions like the merger in the U.S. between Teladoc and Livongo show the growing importance and value of digital and virtual health solutions. Our large patient base, combined with our roster of chronic pain-focused physicians provides us with a vast knowledge base to expand our digital health offering; we chose Pivot because of their Informed Design approach and their experience building solutions in the chronic pain space.”

“Pivot is pleased to partner with NeuPath on this critically important initiative and we look forward to working alongside their healthcare professionals and patients as we transition the company’s leading pain management brands over to effective digital health solutions for their customers,” said Ian Chalmers, founder and creative director at the studio. “Our signature Informed Design investigative approach is a highly co-creative, research activity focused on users throughout the design process that can seamlessly repurpose conventional research knowledge into advanced digital products that, which will allow NeuPath to address the changing needs of their patients.”

About NeuPath
NeuPath is Canada’s largest provider of chronic pain management services that operates under two leading brands in Ontario: CPM – Centres for Pain Management and InMedic Creative Medicine. NeuPath has 12 locations across Ontario with more than 100 licensed healthcare providers that provide care to over 11,000 patients annually. NeuPath offers a comprehensive chronic pain assessment and multi-modal treatment plan based on recommendations by a group of trained physicians to help patients manage their chronic pain and optimize their quality of life. In addition to chronic pain management clinics, NeuPath offers workplace health services as the single, largest cost of chronic pain is lost productivity due to sick days, short and long-term disability claims, and job loss.

About Pivot Design Group
Pivot Design Group is a leading Toronto strategic design and communications studio, specializing in design research, digital UX design, brand design and service design, creating real quality solutions for clients. Since its founding more than 20 years ago, Pivot has shaped its own brand of strategic design, balancing creativity, critical analysis and intuitive thinking through the lens of research and design. The studio’s Informed Design strategic approach delivers consistently exceptional results for enhancing the health and well-being of people and organizations. Over its 20-year history, Pivot Design has successfully completed over 2,000 projects and delivered innovative design solutions to more than 300 clients in different sectors across the business spectrum.

Forward-Looking Statements
This news release contains forward-looking statements. All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, the impact of the COVID-19 pandemic on the Company’s operations and measures implemented in response to the COVID-19 pandemic and the ability of Pivot and the Company to build digital health solutions that are designed to provide chronic pain patients with the tools needed to live a complete and fulfilled life are forward-looking statements. These forward-looking statements reflect the current expectations or beliefs of the Company based on information currently available to the Company. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company. Factors that could cause actual results or events to differ materially from current expectations included in this news release include, among other things, the severity, duration and spread of the COVID-19 outbreak, as well as its direct and indirect impacts that the pandemic may have on the Company’s operations. A comprehensive discussion of these and other risks and uncertainties can be found in the Company’s filing statement dated May 29, 2020 filed on SEDAR under the Company’s profile at www.sedar.com.

Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Although the Company believes that the assumptions underlying the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to their inherent uncertainty.

For more information, please contact:
Stephen Lemieux
slemieux@neupath.com

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS THE RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.